Insight Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,237
| Closed | -$338K | – | 276 |
|
|
2024
Q4 | $338K | Sell |
14,237
-2,996
| -17% | -$71K | 0.06% | 200 |
|
|
2024
Q3 | $441K | Sell |
17,233
-3,207
| -16% | -$82.1K | 0.08% | 173 |
|
|
2024
Q2 | $480K | Sell |
20,440
-4,391
| -18% | -$103K | 0.09% | 155 |
|
|
2024
Q1 | $714K | Sell |
24,831
-4,803
| -16% | -$138K | 0.14% | 112 |
|
|
2023
Q4 | $972K | Buy |
+29,634
| New | +$972K | 0.21% | 85 |
|
|
2023
Q2 | – | Sell |
-16,307
| Closed | -$490K | – | 287 |
|
|
2023
Q1 | $490K | Sell |
16,307
-7,230
| -31% | -$217K | 0.12% | 146 |
|
|
2022
Q4 | $650K | Sell |
23,537
-7,542
| -24% | -$208K | 0.23% | 115 |
|
|
2022
Q3 | $1.02M | Sell |
31,079
-1,774
| -5% | -$58.3K | 0.4% | 61 |
|
|
2022
Q2 | $1.3M | Sell |
32,853
-3,453
| -10% | -$137K | 0.44% | 52 |
|
|
2022
Q1 | $1.67M | Sell |
36,306
-4,217
| -10% | -$194K | 0.5% | 45 |
|
|
2021
Q4 | $2.48M | Sell |
40,523
-4,682
| -10% | -$287K | 0.73% | 28 |
|
|
2021
Q3 | $3.56M | Sell |
45,205
-3,008
| -6% | -$237K | 1.06% | 16 |
|
|
2021
Q2 | $4.07M | Sell |
48,213
-592
| -1% | -$50K | 1.28% | 14 |
|
|
2021
Q1 | $4.34M | Buy |
48,805
+978
| +2% | +$86.9K | 1.37% | 9 |
|
|
2020
Q4 | $4.46M | Buy |
+47,827
| New | +$4.46M | 1.69% | 6 |
|